Drug Discovery and Development of miRNA-Based Nucleotide Drugs for Gastrointestinal Cancer

Related Experiment Video

Updated: Jul 18, 2025

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

7.7K

Hiromichi Sato1,2, Tomoaki Hara1, Sikun Meng1

  • 1Center of Medical Innovation and Translational Research, Department of Medical Data Science, Osaka University Graduate School of Medicine, Yamadaoka 2-2, Suita 565-0871, Osaka, Japan.

Biomedicines
|August 26, 2023
PubMed

Insights

MicroRNAs (miRNAs) show promise in cancer therapy by reprogramming cells and targeting epigenetic and metabolic pathways. This review explores miRNA-based treatments for therapy-resistant cancers, particularly in gastrointestinal organs.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • MicroRNAs (miRNAs) are short non-coding RNAs crucial for regulating cell growth and differentiation.
  • Dysregulation of miRNAs is implicated in cancer development and progression.
  • miRNAs can suppress malignant behaviors in cancer cells, indicating therapeutic potential.

Purpose of the Study:

  • To review recent advancements in microRNA-based therapeutic strategies for therapy-resistant cancers.
  • To highlight the potential of miRNAs in targeting epigenetic and metabolic pathways in cancer.
  • To focus on the application of miRNA therapeutics in gastrointestinal cancers.

Main Methods:

  • Literature review of studies on microRNA-based cancer therapy.
  • Analysis of research on miRNA-induced cellular reprogramming.
  • Examination of studies investigating miRNA effects on epigenetic and metabolic reprogramming in cancer cells.

Main Results:

  • Forced expression of specific miRNAs, such as miR-302, can reprogram cells, similar to transcription factors Oct4, Sox2, Klf4, and c-Myc.
  • miRNAs demonstrate potential to reverse malignant phenotypes in cancer cells.
  • Selective introduction of miRNAs may offer anti-cancer effects via epigenetic and metabolic modulation.

Conclusions:

  • MicroRNA-based therapies represent a promising approach for overcoming resistance in cancer treatment.
  • Targeting epigenetic and metabolic pathways with miRNAs offers a novel strategy against cancer.
  • Further research into miRNA therapeutics is warranted, especially for gastrointestinal malignancies.
Keywords:
epigenetic reprogramminggastrointestinal cancersinduced pluripotent stem cellsmiRNA-modified nucleotide drugs

More Related Videos

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy09:40

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Published on: October 4, 2019

5.7K
An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells09:45

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells

Published on: May 21, 2019

8.4K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.8K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
54